As even further evidenced by this settlement, the DOJ and SEC continue to sign the risks linked to ill-defined swimming pools of reimbursable distributor fees (e.g. “advertising” or “administration” costs), the use of free samples, rebates, and various rate concessions. The Alcon and Novartis AG DPAs certainly are a reminder of the necessit